Fiber for Women: Hormonal Health, the Estrobolome, and Life Stage Optimization
By Cole Stubblefield | Last Updated: March 2026 | 14 min read
Your gut microbiome contains a subset of bacteria that directly regulate your estrogen levels. It is called the estrobolome. Dietary fiber is the primary tool for keeping it healthy. Here is what every woman needs to know.
Affiliate Disclosure: This article contains affiliate links. If you purchase through our links, we may earn a commission at no additional cost to you. See our full Affiliate Disclosure.
Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before changing your diet or supplement protocol, particularly regarding hormonal health, reproductive conditions, or pregnancy. See our Medical Disclaimer.
Table of Contents
- The Estrobolome: The Gut-Hormone Connection Most Women Have Never Heard Of
- How Dietary Fiber Regulates the Estrobolome
- Fiber and PCOS: Insulin Resistance, Androgens, and the Microbiome
- Fiber and Endometriosis: The Inflammatory Connection
- Fiber During Perimenopause and Menopause
- Fiber and Breast Cancer Risk: What the Evidence Shows
- Fiber During Pregnancy and the Postpartum Period
- Fiber Needs Across Life Stages: How Requirements Change
- The Best Fiber Sources for Women's Hormonal Health
- Closing the Gap: When Food Is Not Enough
- Frequently Asked Questions
The Estrobolome: The Gut-Hormone Connection Most Women Have Never Heard Of
Most people understand that gut health affects digestion. Far fewer know that the gut microbiome directly regulates circulating estrogen levels.
The estrobolome is the collection of microbial genes within gut bacteria that are capable of metabolizing and modulating estrogen. It was formally defined in 2011 as the aggregate of all enteric bacteria capable of metabolizing estrogen, and it is increasingly recognized as one of the most important regulators of estrogen exposure across the female lifespan.
Here is how it works. The liver conjugates, or chemically deactivates, estrogens through glucuronidation and sulfation, attaching a glucuronide or sulfate group that makes them water-soluble for excretion through bile. These conjugated estrogens pass through the bile duct into the small intestine and are transported to the colon for excretion.
In the colon, bacteria that encode the enzyme beta-glucuronidase cleave the glucuronide group off conjugated estrogens, reactivating them. These deconjugated estrogens are then reabsorbed through the intestinal wall into systemic circulation rather than being excreted. The estrobolome is therefore a key regulator of how much active estrogen recirculates through the body rather than being eliminated.
A well-functioning, diverse estrobolome maintains estrogen homeostasis. An overactive estrobolome, driven by dysbiosis that elevates beta-glucuronidase activity above normal levels, increases estrogen reabsorption and drives estrogen excess. An underactive estrobolome, depleted by poor diet or dysbiosis that reduces beta-glucuronidase to below-normal levels, reduces estrogen reabsorption and contributes to estrogen deficiency states.
Both extremes have clinical consequences. Elevated circulating estrogen driven by an overactive estrobolome is associated with endometriosis, PCOS, estrogen receptor-positive breast cancer, and uterine fibroids. Depleted estrogen from an underactive estrobolome contributes to the bone loss, cardiovascular risk, cognitive changes, and vasomotor symptoms associated with estrogen deficiency in perimenopause and post-menopause.
Dr. Siobhain O'Mahony, senior lecturer at University College Cork and lead researcher with APC Microbiome Ireland, stated in October 2025 that the estrobolome directly influences hormonal balance via estrogen recycling and that its targeted hormonal role sets it apart from microbes involved in digestion or immunity. She noted that dysregulation has been linked to multiple health conditions and that maintaining estrobolome balance is key to reproductive, cardiovascular and cognitive health.
How Dietary Fiber Regulates the Estrobolome
Dietary fiber influences the estrobolome through two converging mechanisms.
The first is beta-glucuronidase activity modulation. High-fiber diets consistently reduce beta-glucuronidase activity in the gut by shifting the microbiome composition away from the bacterial species that produce it in excess, particularly certain Bacteroides and Clostridium species, and toward the beneficial species that maintain normal enzymatic balance. By normalizing beta-glucuronidase activity, high-fiber diets reduce excessive estrogen reabsorption without eliminating the basal level of estrogen recycling that the body needs.
A 2025 Clinical Nutrition Open Science scoping review examining dietary fibers, the gut microbiota, and health outcomes in breast cancer survivors confirmed that dietary fibers consistently correlate with beneficial changes in gut microbiome composition, including increased diversity and beneficial bacterial abundance while reducing harmful bacteria linked to estrogen reabsorption. The review described fiber as influencing the estrobolome by serving as fermentation substrate and producing short-chain fatty acids that reshape the microbial community governing estrogen metabolism.
The second mechanism is indirect, through the anti-inflammatory and microbiome-diversifying effects of fiber that broadly support estrobolome health. A diverse, fiber-fed microbiome maintains the balanced bacterial community within which the estrobolome operates normally. A depleted, dysbiotic microbiome, common in women eating the typical American average of 12 to 15 grams of fiber per day, creates the microbial imbalance that dysregulates beta-glucuronidase activity and disrupts estrogen homeostasis.
High-fiber diets and some fermented foods have been shown to support beneficial estrobolome bacteria and enzyme balance, and probiotics and prebiotics may also restore estrobolome function. This is a growing area of clinical interest, with researchers at APC Microbiome Ireland and elsewhere exploring targeted synbiotics specifically designed to influence estrogen metabolism through the gut.
Fiber and PCOS: Insulin Resistance, Androgens, and the Microbiome
Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, affecting 7 to 10% of women with a uterus. Its hallmarks include irregular or absent menstrual cycles, elevated androgens, and ovarian cysts. Over 80% of women with PCOS have insulin resistance, the metabolic dysfunction that drives elevated blood glucose and insulin levels and increases risk of weight gain, type 2 diabetes, and cardiovascular disease across the lifespan.
Dietary fiber addresses PCOS through three intersecting mechanisms.
The most direct is insulin sensitivity improvement. Elevated insulin in PCOS drives the ovarian overproduction of androgens including testosterone by stimulating ovarian theca cells. Reducing insulin levels and improving insulin sensitivity reduces this androgenic signal. Dietary fiber, particularly viscous soluble fiber and resistant starch, produces meaningful improvements in fasting insulin, postprandial glucose, and insulin sensitivity through the mechanisms described in the fiber and blood sugar article. A 2026 Frontiers in Endocrinology review examining dietary interventions for modulating the gut microbiome in PCOS management confirmed that dietary fibers are vital in protecting the gut and improving insulin sensitivity, noting that prebiotic fiber sources including garlic, onions, chicory root, artichokes, bananas, and asparagus provide microbiota-accessible carbohydrates that improve both gut and metabolic function in PCOS.
The second mechanism is microbiome rebalancing. Women with PCOS consistently show reduced gut microbiome diversity compared to healthy controls, with lower Bifidobacterium and Akkermansia populations and higher pro-inflammatory Enterobacteriaceae. This dysbiotic pattern worsens insulin resistance, elevates systemic inflammation, and dysregulates estrogen and androgen metabolism simultaneously. High-fiber dietary patterns that restore microbiome diversity address the PCOS microbiome phenotype directly, improving the gut environment that drives both metabolic and hormonal PCOS symptoms.
The third mechanism is anti-inflammatory activity. PCOS is characterized by chronic low-grade inflammation, with elevated IL-6 and TNF-alpha contributing to insulin resistance, ovarian dysfunction, and the metabolic complications that accumulate over the lifespan. The SCFA-mediated anti-inflammatory mechanisms that dietary fiber drives through butyrate production and gut barrier maintenance reduce this inflammatory background, improving multiple aspects of the PCOS symptom cluster simultaneously.
PCOS does not resolve at perimenopause. It evolves from primarily a reproductive disorder to primarily a metabolic one, with increased cardiovascular risk in post-menopausal women with PCOS history. A high-fiber dietary pattern maintained throughout adulthood provides metabolic protection at every life stage, not only during reproductive years.
Fiber and Endometriosis: The Inflammatory Connection
Endometriosis affects approximately 10% of reproductive-age women globally. It is an inflammatory condition in which endometrial-like tissue grows outside the uterus, driven by estrogen, inflammatory cytokines, and immune dysfunction. Its association with gut health operates through two of the same pathways as PCOS: estrogen dysregulation through the estrobolome and chronic systemic inflammation.
Estrogen dominance, whether from endogenous overproduction, elevated estrogen reabsorption from an overactive estrobolome, or both, fuels endometrial tissue growth outside the uterus. Normalizing estrogen recycling through estrobolome support, which dietary fiber facilitates through beta-glucuronidase activity modulation, reduces the estrogen load available to drive endometrial proliferation.
The chronic systemic inflammation that characterizes endometriosis drives both the pain symptoms and the progressive tissue growth associated with the condition. Dietary fiber's anti-inflammatory effects, operating through gut barrier protection, SCFA-mediated NF-kB inhibition, and microbiome-driven reduction of circulating LPS, reduce the pro-inflammatory environment that endometriosis depends on.
Women with endometriosis also show altered gut microbiome composition compared to healthy controls, with reduced Lactobacillus populations and elevated inflammatory species. High-fiber dietary patterns that support Lactobacillus, Bifidobacterium, and Faecalibacterium prausnitzii populations address this dysbiotic pattern alongside the inflammation and estrogen dysregulation mechanisms.
Dietary intervention does not treat endometriosis as a substitute for medical management. For women managing endometriosis, a high-fiber dietary pattern represents a meaningful complement to conventional hormonal therapy by addressing two of the underlying biological pathways that drive the condition.
Fiber During Perimenopause and Menopause
Perimenopause, the transition period lasting several years to a decade before menopause, involves progressive estrogen decline, increasing hormonal fluctuation, and the onset of vasomotor symptoms including hot flushes, night sweats, mood changes, disrupted sleep, and cognitive variability. The gut microbiome changes during this transition in ways that have direct relevance to estrogen management.
As estrogen declines, the microbial composition of the gut shifts. Estrogen itself supports the growth of certain beneficial bacterial species, and its decline is associated with reduced Lactobacillus dominance and decreasing microbiome diversity. The estrobolome, previously calibrated to recirculate appropriate amounts of estrogen, now operates in a lower-estrogen environment where even small increases or decreases in beta-glucuronidase activity produce relatively larger hormonal effects.
Maintaining estrogen homeostasis during this transition requires an estrobolome that is functioning well, not overactive or underactive. Dietary fiber supports this by maintaining the microbiome diversity and composition that keeps beta-glucuronidase activity in the normal physiological range.
Beyond estrogen management, dietary fiber during perimenopause and menopause addresses four specific health transitions that accelerate during this period.
Cardiovascular risk increases significantly after menopause as estrogen's cardioprotective effects diminish. Fiber's LDL-lowering, triglyceride-reducing, and anti-inflammatory effects directly address the cardiovascular risk factors that elevate during this life stage. The beta-glucan in oats and the bile acid binding of psyllium are particularly relevant here.
Bone density declines as estrogen falls, driven partly by increased osteoclast activity and partly by calcium absorption changes. Dietary fiber supports bone density indirectly through short-chain fatty acid production. Butyrate and propionate have been shown to reduce osteoclast activity and support osteoblast function, contributing to bone maintenance alongside adequate calcium and vitamin D intake.
Metabolic changes including declining insulin sensitivity, weight redistribution toward central adiposity, and worsening lipid profiles are common during the menopausal transition. Fiber's glycemic and metabolic benefits address each of these directly.
Mood and cognitive symptoms during perimenopause have a gut-brain axis component. Serotonin production, partly gut-derived and influenced by microbial composition, declines alongside estrogen. Maintaining a fiber-fed, diverse microbiome supports gut-derived serotonin synthesis and reduces the neuroinflammatory burden that contributes to perimenopausal mood symptoms.
Fiber and Breast Cancer Risk: What the Evidence Shows
The estrobolome connection between dietary fiber and breast cancer risk represents one of the most clinically significant intersections in this article.
Estrogen receptor-positive breast cancer, which accounts for approximately 70 to 80% of all breast cancer diagnoses, is driven by estrogen exposure. Cumulative lifetime estrogen exposure is one of the strongest established risk factors for ER-positive breast cancer. The estrobolome's role in regulating estrogen reabsorption from the gut means that estrobolome dysbiosis that elevates beta-glucuronidase activity increases circulating estrogen and therefore increases cumulative lifetime exposure to the hormone that drives the majority of breast cancers.
Dietary fiber reduces this risk pathway through multiple mechanisms. By normalizing beta-glucuronidase activity, it reduces excessive estrogen reabsorption. By increasing stool bulk and accelerating transit, it reduces the time during which deconjugated estrogens remain available for reabsorption in the colon. By driving microbiome changes that reduce harmful bacteria linked to estrogen reabsorption and increase beneficial bacteria associated with normal estrogen metabolism, it reshapes the estrobolome toward a healthier functional profile.
The 2025 Clinical Nutrition Open Science scoping review found that dietary fibers consistently correlate with beneficial changes in gut microbiome composition in breast cancer survivors, reducing harmful bacteria linked to estrogen reabsorption and influencing estrogen metabolism through the estrobolome. The review identified greater gut microbiota diversity resulting from increased fiber consumption as directly increasing estrogen metabolism efficiency and consequently improving breast cancer treatment outcomes.
A 2025 International Journal of Cancer review of the estrobolome hypothesis identified low and high fiber diets as important external factors that can shape the broader gut microbiome and potentially influence estrobolome processes including inflammation and immune modulation.
This is not a claim that dietary fiber prevents breast cancer. The research is associational and mechanistic, not proof of causation in the clinical trial sense. What the evidence does support clearly is that a high-fiber diet supports a better-functioning estrobolome that maintains more physiological estrogen metabolism, and that this microbiome-estrogen pathway is a plausible and increasingly studied contributor to the associations between dietary patterns and breast cancer risk observed in population studies.
Fiber During Pregnancy and the Postpartum Period
Fiber requirements increase slightly during pregnancy. The Dietary Guidelines for Americans recommend a minimum of 28 grams per day for pregnant women, while clinical research suggests higher intakes produce better metabolic and microbiome outcomes for both mother and developing infant.
During pregnancy, dietary fiber serves several specific functions that are distinct from general adult fiber benefits.
Gestational diabetes prevention is one of the most clinically important. Pregnancy induces physiological insulin resistance to prioritize glucose delivery to the fetus. Women who already have borderline insulin sensitivity are at elevated risk of gestational diabetes, a condition associated with complications for both mother and baby. High-fiber dietary patterns that improve insulin sensitivity and blunt postprandial glucose spikes reduce gestational diabetes risk through the same glycemic mechanisms described in the fiber and blood sugar article.
Constipation is one of the most common discomforts of pregnancy, driven by progesterone-mediated relaxation of intestinal smooth muscle and physical compression of the colon by the growing uterus. Adequate dietary fiber maintains gut motility during pregnancy without the risks associated with stimulant laxatives. Soluble fiber from oats and psyllium and insoluble fiber from vegetables and whole grains are both safe and effective for pregnancy-related constipation when consumed with adequate water.
The maternal gut microbiome during pregnancy shapes the infant's initial microbiome through the birth process and breastfeeding. A diverse, fiber-fed maternal microbiome transmits a more beneficial initial microbial community to the infant. Research has linked maternal dietary diversity and fiber intake during pregnancy to infant microbiome diversity at birth and during the first year of life, with potential implications for the infant's metabolic and immune development.
Preeclampsia, a serious pregnancy complication involving hypertension and organ stress, is associated with systemic inflammation and gut dysbiosis. High-fiber dietary patterns that reduce systemic inflammation and maintain gut barrier integrity may contribute to preeclampsia risk reduction, though the evidence base in humans is still developing.
During the postpartum period, maternal gut microbiome restoration after the disruptions of labor, delivery, and breastfeeding is an area of growing clinical interest. High-fiber dietary patterns during the postpartum period support microbiome recovery and provide the metabolic benefits that address the insulin resistance, inflammation, and hormonal changes of the fourth trimester.
Fiber Needs Across Life Stages: How Requirements Change
The clinical fiber target of 14 grams per 1,000 calories consumed applies across adult life stages but the absolute gram count varies with caloric intake, which itself changes with life stage and activity level.
During adolescence and early adulthood, when caloric intake is typically highest, fiber requirements are also highest. Active women in their 20s consuming 2,000 to 2,400 calories daily have a fiber target of 28 to 34 grams per day.
During reproductive adulthood, fiber requirements are stable at the caloric intake benchmark. For most women, this means 28 to 38 grams per day depending on activity level and caloric intake. PCOS and endometriosis management both benefit from fiber intake at the upper end of this range.
During pregnancy, the minimum recommended intake rises to 28 grams per day under dietary guidelines, with clinical evidence supporting higher intakes for metabolic and microbiome benefits. Caloric intake increases during pregnancy, which raises the proportional fiber target under the 14-grams-per-1,000-calories benchmark.
During perimenopause and postmenopause, caloric requirements often decline while the health consequences of low fiber intake become more acute through the cardiovascular, bone, and metabolic changes of this life stage. Maintaining fiber intake at the clinical target despite lower caloric intake requires deliberate food selection. Fiber density per calorie becomes the key metric: prioritizing foods that deliver high fiber per calorie, particularly legumes, seeds, and non-starchy vegetables, allows the fiber target to be met within a lower caloric budget.
Use our Precision Fiber Target Calculator to calculate your personalized fiber target based on your current body weight, age, sex, and activity level.
The Best Fiber Sources for Women's Hormonal Health
Beyond the general high-fiber foods described in our ranked fiber foods guide, several foods have specific relevance to women's hormonal health through the estrobolome and anti-inflammatory pathways.
Flaxseed
Ground flaxseed provides soluble and insoluble fiber alongside lignans, which are plant compounds with weak estrogenic activity that compete with endogenous estrogen for estrogen receptor binding. In estrogen-dominant states, dietary lignans from flaxseed may partially buffer the effects of elevated circulating estrogen by occupying receptors with a lower-potency estrogen-like compound. In estrogen-deficient states, lignans provide mild estrogenic activity that partially compensates for declining endogenous production. Two tablespoons of ground flaxseed per day is the dose most commonly studied in clinical research on lignan effects in women.
Cruciferous Vegetables
Broccoli, Brussels sprouts, kale, and cabbage provide insoluble fiber alongside indole-3-carbinol and diindolylmethane, compounds that promote the conversion of estrogen to less potent metabolites through 2-hydroxylation rather than the more potent 16-alpha-hydroxylation pathway. This metabolite shift reduces the estrogenic burden at the tissue level independently of total circulating estrogen concentration. Regular cruciferous vegetable consumption is one of the most evidence-backed dietary strategies for estrogen metabolism optimization.
Legumes
Legumes provide the most complete fiber type profile of any food category alongside phytoestrogens including isoflavones in soybeans and other legumes. Dietary isoflavones from legume consumption have been studied extensively in perimenopause and menopause for their ability to partially compensate for declining estrogen at estrogen receptors. The evidence for isoflavone effects on hot flushes is moderate, with meta-analyses showing modest but significant reductions in vasomotor symptom frequency in perimenopausal women. The fiber content of legumes independently supports the estrobolome through the microbiome-diversifying effects described above.
Berries
Berries provide pectin alongside polyphenols including anthocyanins that are selectively fermented by Bifidobacterium species in the gut. The combination of prebiotic pectin and polyphenol fermentation makes berries one of the most microbiome-supportive fruit categories available and specifically supports the Bifidobacterium populations that are associated with healthier estrobolome function.
Oats
Oats provide beta-glucan that drives Bifidobacterium and Lactobacillus growth alongside butyrate-producing Firmicutes. The specific Bifidobacterium stimulation from oat beta-glucan fermentation is relevant to estrobolome health because Bifidobacterium populations are associated with more balanced beta-glucuronidase activity and healthier estrogen recycling profiles.
Closing the Gap: When Food Is Not Enough
Even women eating a careful high-fiber diet may find it difficult to consistently hit their personalized fiber target while also addressing the specific hormonal health mechanisms described in this article. Three targeted supplement categories close this gap while providing specific relevance to women's hormonal health.
Clinical synbiotics are the most complete supplement intervention for estrobolome support. A high-quality synbiotic combines probiotic strains with prebiotic fiber substrates specifically matched to support those strains' colonization and activity. Research has confirmed that a probiotic blend can help maintain serum estrogen in healthy peri- and postmenopausal women over a 12-week period, pointing toward synbiotics as promising tools for estrobolome support during hormonal transitions. The Seed DS-01 Daily Synbiotic, featured on our Shop page, combines 24 clinically studied strains with a prebiotic outer capsule designed to survive transit and deliver both strains and substrate to the colon where estrobolome function occurs.
Microbiome diagnostic testing provides the individual-level insight needed to move from population-average recommendations to personalized estrobolome support. The Viome Gut Intelligence test, available on our Shop page, uses metatranscriptomic RNA sequencing to identify which bacteria are metabolically active in your gut, including the beta-glucuronidase-producing species that directly influence estrogen reabsorption. For women with estrogen-related conditions including PCOS, endometriosis, or symptoms of estrogen dominance, knowing your specific estrobolome composition provides a more targeted foundation for dietary and supplement decisions than generic fiber recommendations.
Psyllium husk provides the highest-concentration soluble fiber available in a single supplement, supporting both the bile acid binding mechanism that accelerates estrogen excretion and the microbiome-supporting fermentation substrate that feeds beneficial estrobolome bacteria. One tablespoon per day in addition to a high-fiber diet provides a meaningful daily increment toward both total fiber target and estrobolome-specific support. See our Shop page for our current psyllium recommendations.
Frequently Asked Questions
Does fiber help balance hormones? Dietary fiber influences hormone balance indirectly through the estrobolome mechanism described in this article. By supporting a diverse gut microbiome with balanced beta-glucuronidase activity, high-fiber diets help maintain estrogen homeostasis rather than directly producing or eliminating hormones. The effect is meaningful for women with estrogen-related conditions but operates through a microbiome-mediated pathway rather than a direct hormonal one.
How does fiber help with PCOS? Fiber improves PCOS outcomes primarily through insulin sensitivity improvement, which reduces the elevated insulin that drives ovarian androgen overproduction in PCOS. It also supports microbiome diversity that is depleted in PCOS and reduces the chronic systemic inflammation that exacerbates PCOS metabolic symptoms. The combined metabolic, microbiome, and anti-inflammatory benefits of high-fiber eating address multiple PCOS mechanisms simultaneously.
Can fiber help with hot flushes? There is no direct clinical trial evidence that dietary fiber reduces hot flush frequency. However, fiber-driven microbiome improvements support a healthier estrobolome that maintains more physiological estrogen recycling during the perimenopausal transition, which may reduce the amplitude of estrogen fluctuations that trigger vasomotor symptoms in some women. Legume-derived isoflavones, consumed alongside high-fiber eating, have more direct clinical evidence for modest hot flush reduction.
How much fiber should women eat during pregnancy? The Dietary Guidelines for Americans recommend a minimum of 28 grams per day during pregnancy. Clinical research supports higher intakes for metabolic and microbiome benefits, with the 14-grams-per-1,000-calories benchmark pointing toward 28 to 35 grams per day for most pregnant women at typical caloric intakes. Always consult your obstetrician or midwife about specific dietary recommendations during pregnancy.
Does dietary fiber affect birth control effectiveness? There is no clinical evidence that dietary fiber intake affects the absorption or effectiveness of oral contraceptives at typical fiber intake levels. The caveat that applies to fiber and medication absorption, specifically the recommendation to take medications two hours before or after psyllium husk supplementation, relates specifically to psyllium gel's potential to impair absorption of medications taken simultaneously. Standard dietary fiber from food does not produce this interaction at typical intake amounts.
Is a high-fiber diet safe during breastfeeding? Yes. High-fiber dietary patterns are safe and beneficial during breastfeeding. Dietary fiber supports maternal gut microbiome health during the postpartum period and does not negatively affect breast milk composition. The maternal microbiome influences the infant's microbiome through breast milk, and a diverse, fiber-fed maternal microbiome may support the transmission of a more beneficial microbial community to the nursing infant.
Start Your Protocol
Step 1: Calculate your personalized daily fiber target for your current life stage
Step 2: Generate a clinical meal plan incorporating the hormone-supportive foods described in this article
Step 4: Read the complete fibermaxxing protocol guide
This article is for educational purposes only and does not constitute medical advice. It does not address diagnosis or treatment of any hormonal, reproductive, or oncological condition. Consult your physician or a qualified healthcare provider for personalized guidance on hormonal health, pregnancy, PCOS, endometriosis, or cancer risk. See our full Medical Disclaimer.
Sources: Plottel CS, Blaser MJ. Microbiome and Malignancy. Cell Host and Microbe, 2011; O'Mahony S, Prpa D. Gut Microbiome's Hidden Role in Women's Hormonal Health. NutraIngredients, October 2025; Larnder AH, Manges AR. The Estrobolome: Estrogen-Metabolizing Pathways of the Gut Microbiome and Their Relation to Breast Cancer. International Journal of Cancer, April 2025; Zengul AG, Demark-Wahnefried W et al. Associations between Dietary Fiber, the Fecal Microbiota and Estrogen Metabolism in Postmenopausal Women with Breast Cancer. Frontiers in Oncology, 2021; Clinical Nutrition Open Science Scoping Review: Associations between Dietary Fiber, the Gut Microbiota, and Health Outcomes in Breast Cancer Survivors, April 2025; Dietary Interventions for Modulating the Gut Microbiome in PCOS Management. Frontiers in Endocrinology, 2026; Wright PJ et al. Perspectives of Peri-Postmenopausal Women with PCOS. Frontiers in Global Women's Health, July 2025; Dietary Guidelines for Americans 2020 to 2025, USDA and HHS; Slavin J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients, 2013; Dahl WJ, Zeng Y. Nutrition and the Gut Microbiome: A Symbiotic Dialogue. Frontiers in Nutrition, 2026; Gut Health and Fertility Guide: Your 2026 Wellness Roadmap. Nostrabiome, January 2026.